IRIS
BARISON, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.906
AS - Asia 5.664
EU - Europa 5.507
SA - Sud America 1.271
AF - Africa 144
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 8
Totale 22.513
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.381
SG - Singapore 2.098
RU - Federazione Russa 1.472
CN - Cina 1.395
IT - Italia 1.283
BR - Brasile 990
VN - Vietnam 863
GB - Regno Unito 855
DE - Germania 570
HK - Hong Kong 391
CA - Canada 347
UA - Ucraina 298
BD - Bangladesh 279
FR - Francia 224
FI - Finlandia 161
SE - Svezia 139
IN - India 136
MX - Messico 121
DK - Danimarca 118
AR - Argentina 107
PL - Polonia 91
TR - Turchia 77
ES - Italia 67
ID - Indonesia 64
IL - Israele 64
NL - Olanda 62
ZA - Sudafrica 59
IQ - Iraq 58
EC - Ecuador 56
IE - Irlanda 51
JP - Giappone 45
CO - Colombia 29
UZ - Uzbekistan 27
AT - Austria 25
MA - Marocco 23
PK - Pakistan 23
VE - Venezuela 23
AE - Emirati Arabi Uniti 19
PY - Paraguay 19
EG - Egitto 16
SA - Arabia Saudita 16
CL - Cile 14
LT - Lituania 14
MY - Malesia 13
JO - Giordania 12
CH - Svizzera 11
EU - Europa 11
PE - Perù 11
TN - Tunisia 11
UY - Uruguay 11
JM - Giamaica 9
KE - Kenya 9
HN - Honduras 8
PH - Filippine 8
AU - Australia 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
KZ - Kazakistan 7
BE - Belgio 6
CZ - Repubblica Ceca 6
GR - Grecia 6
IR - Iran 6
NI - Nicaragua 6
PS - Palestinian Territory 6
BH - Bahrain 5
GY - Guiana 5
HR - Croazia 5
KG - Kirghizistan 5
LB - Libano 5
NP - Nepal 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BB - Barbados 4
BO - Bolivia 4
BY - Bielorussia 4
ET - Etiopia 4
PT - Portogallo 4
RO - Romania 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
CG - Congo 3
HU - Ungheria 3
KR - Corea 3
KW - Kuwait 3
LV - Lettonia 3
MD - Moldavia 3
OM - Oman 3
RS - Serbia 3
SM - San Marino 3
SN - Senegal 3
SV - El Salvador 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
GE - Georgia 2
GP - Guadalupe 2
GT - Guatemala 2
KH - Cambogia 2
Totale 22.477
Salva come PNG Salva come JPEG
Città #
Dallas 1.523
Singapore 1.098
Ashburn 704
San Jose 650
Beijing 602
Southend 444
Los Angeles 370
Hong Kong 357
Chicago 350
Houston 323
Chandler 314
Moscow 287
Ho Chi Minh City 264
Fairfield 252
Ann Arbor 242
Woodbridge 225
New York 224
San Mateo 200
Hanoi 161
Wilmington 159
Seattle 152
Buffalo 133
Salt Lake City 132
Cambridge 130
The Dalles 130
Falls Church 129
São Paulo 116
Jacksonville 112
Dearborn 108
Santa Clara 107
Ottawa 101
Rome 96
Boardman 95
Tampa 93
Hefei 91
Lauterbourg 91
Helsinki 90
Pisa 88
Milan 80
Portsmouth 79
Stevenage 79
Warsaw 78
Munich 72
Montreal 70
Dong Ket 68
Brooklyn 67
London 66
Council Bluffs 61
Elk Grove Village 61
Mexico City 61
Orem 60
Lawrence 57
Beauharnois 56
Tel Aviv 55
Dublin 49
Denver 46
Florence 43
Istanbul 43
Frankfurt am Main 42
Toronto 42
Johannesburg 41
Tokyo 40
Chennai 39
San Diego 39
Stockholm 39
Atlanta 37
Phoenix 36
Sterling 35
Lancaster 34
Rio de Janeiro 34
Poplar 32
Amsterdam 31
Boston 29
Da Nang 28
Campinas 27
Tashkent 26
Turku 26
Guayaquil 24
Haiphong 24
Bari 22
Lappeenranta 22
Miami 22
Palermo 22
Redwood City 22
Central District 21
Montréal 21
Mumbai 21
Nuremberg 21
Naples 20
Genoa 19
San Francisco 19
Belo Horizonte 18
Biên Hòa 18
Ankara 17
Baghdad 17
Dulles 17
Manchester 17
Columbus 16
Detroit 16
Guangzhou 16
Totale 13.103
Salva come PNG Salva come JPEG
Nome #
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.569
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 691
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 438
A simple echocardiographic score to rule out cardiac amyloidosis 375
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 349
A simple echocardiographic score to rule out cardiac amyloidosis 345
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 333
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 330
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 326
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 324
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 323
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 312
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 311
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 306
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 305
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 300
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 299
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 298
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 295
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 293
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 283
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 281
Sex-related differences in chronic heart failure 279
Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy 268
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 262
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 261
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 259
Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling 257
Leiomyosarcoma of the inferior vena cava in a patient with Budd-Chiari syndrome 257
Update sui biomarcatori nello scompenso cardiaco. 257
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 252
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 252
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 250
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 248
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 241
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 238
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 238
Role of Imaging in Cardiomyopathies 235
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 235
Valvular heart disease in patients with cardiac amyloidosis 234
Fibrosis and mortality in patients with dilated cardiomyopathy [2] 234
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 232
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 231
Cardiac magnetic resonance in patients with muscular dystrophies 228
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 227
Perspectives in noninvasive imaging for chronic coronary syndromes 224
Cardiovascular disease and COVID-19: les liaisons dangereuses 222
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 215
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 214
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology 213
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 212
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 211
CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: An international Registry 210
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 209
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 205
Molecular autopsy of sudden cardiac death in the genomics era 205
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 203
Increased extracellular volume fraction in nonischaemic dilated cardiomyopathy predicts worse outcomes independently of medical therapy 200
Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation 199
Prevalence and prognostic impact of nonischemic late gadolinium enhancement in stress cardiac magnetic resonance 198
Colchicine for the treatment of coronary artery disease 192
Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy 189
Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction. A Study of the Collaborative Registry on CMR in STEMI 189
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 188
Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction 188
Colchicine added to standard therapy further reduces fibrosis in pigs with myocardial infarction 187
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 187
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology 183
Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry 180
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: Results from a long-term follow-up multicentre study 174
Troponin in non-ischaemic dilated cardiomyopathy 169
Early or deferred cardiovascular magnetic resonance after ST-segment-elevation myocardial infarction for effective risk stratification 168
Prevalence and Correlates of Dilated and Non-Dilated Left Ventricular Cardiomyopathy in Transfusion-Dependent Thalassemia: Data from a National, Multicenter, Observational Registry 162
Multimodality Imaging in a Patient With MINOCA and Anomalous Coronary Artery 162
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 156
Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset 156
Heart & kidney failure: Who's afraid of renin angiotensin system blockade? 155
Treatment of cardiac transthyretin amyloidosis: an update 152
Partial Lipodystrophy and LMNA p.R545H Variant 149
Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence 147
Magnetic Resonance for Differential Diagnosis of Left Ventricular Hypertrophy: Diagnostic and Prognostic Implications 143
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 138
Magnetic Resonance to Diagnose Cardiac Amyloidosis: Is it Already Time to Discard Contrast Agents? 126
The Barthel Index in elderly acute heart failure patients. Frailty matters 124
The unbearable underreporting of comorbidities in heart failure clinical trials 123
Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction 120
Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis 120
Response to ‘Is the left atrium the key in the amyloid imaging lock?’ 113
Extracellular Volume in Dilated Cardiomyopathy: A New Prognostic Marker on Top of Late Gadolinium Enhancement? 107
Letter by Aimo et al Regarding Article, "development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies" 101
European task force reclassification of dilated and non-dilated cardiomyopathies identifies a high arrhythmic-risk overlap phenotype 89
Prognostic role of updated Lake Louise criteria for the diagnosis of acute myocarditis (ITAMY-mapping study) 68
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathy 60
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 49
Photon-Counting Computed Tomography for Tissue Characterization in Patients With a Left Ventricular Hypertrophic Phenotype 44
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 43
A Novel SCN5A Missense Variant Associated With Familial Non-Dilated Left Ventricular Cardiomyopathy 35
Electrocardiographic abnormalities in patients with cardiomyopathies 35
Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy 30
null 29
Totale 22.631
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.729
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021193 0 0 0 0 0 0 0 0 0 0 0 193
2021/20221.102 122 166 37 114 32 46 106 183 82 122 18 74
2022/2023689 62 49 31 94 88 99 11 60 105 16 52 22
2023/2024532 41 18 107 57 22 51 48 23 12 14 21 118
2024/20255.130 45 54 208 67 166 214 505 970 327 915 932 727
2025/202611.487 736 1.666 1.365 1.555 1.265 769 1.052 612 762 826 810 69
Totale 22.670